Background Device closure of atrial septal defect (ASD) and patent foramen ovale (PFO) are
both associated with short‐and long‐term complications. Our knowledge of the complication …

2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A
Report of the American College of Cardiology/American Heart Association Task Force on …

The recommendations listed in this guideline are, whenever possible, evidence-based. An
initial extensive evidence review, which included literature derived from research involving …

Interventions in adults with congenital heart disease (ACHD) focus on surgical and
percutaneous interventions in light of rapidly evolving ACHD clinical practice. To bring rigour …

Approximately 50 million adults worldwide have known congenital heart disease (CHD).
Among the most common types of CHD defects in adults are atrial septal defects and …

The objective of this study was to determine the initial safety and results of unrestricted multi-
institution routine community use of the Amplatzer Septal Occluder (ASO) for atrial septal …

The objective of this study was to evaluate a new technique of sizing atrial septal defects
(ASDs) for transcatheter device closure. ASD closure using the Amplatzer septal occluder …

Background A trans-catheter closure of an atrial septal defect (ASD) is efficient. Balloon
sizing (BS) during the catheterization leads to an overestimation of ASD size. Three …

Background: Device erosion is a very rare but potentially fatal complication of ASD occlusion
by the Amplatzer Septal Occluder (ASO). After reviewing cases of device erosion …

Background Many adult patients with secundum-type atrial septal defects (ASDs) are able to
have these defects fixed percutaneously. Traditionally, this has involved an assessment of …